taking berberine and semaglutide together Ozempic Together: Safety Guide Berberine and Wegovy Together: Safety

our team of medical professionals can help you find the right IV package and determine the best time to take glutathione

Your provider will use your lipid panel results, along with other factors, to get a complete picture of your heart health

AOD-9604 Nasal Spray is a specialized peptide formulated to support fat metabolism and body composition

The superoxide radical switch in the biology of nitric oxide and peroxynitrite

Clinical Trial Results STEP Trials (Semaglutide) The STEP program studied semaglutide 2.4 mg weekly in overweight/obese adults: STEP 1 : 16.9% average weight loss over 68 weeks vs 2.4% placebo STEP 2 (T2D patients): 9.6% weight loss STEP 3 (with behavioral therapy): 16.0% weight loss STEP 5 (2-year data): 15.2% sustained weight loss SURMOUNT Trials (Tirzepatide) The SURMOUNT program studied tirzepatide at 5mg, 10mg, and 15mg weekly: SURMOUNT-1 : 20.9% average weight loss at 15mg over 72 weeks vs 3.1% placebo SURMOUNT-2 (T2D patients): 14.7% at 15mg SURMOUNT-3 (with lifestyle intervention): 26.6% at highest dose SURMOUNT-4 (maintenance): continued weight loss vs weight regain on placebo Head-to-Head No large head-to-head trial has directly compared them at optimal doses for weight loss

Results Study design and anthropometry We analyzed data from the ongoing multicenter LI study PLIS that recruited individuals with prediabetes in study centers throughout Germany within the framework of the German Center for Diabetes Research (DZD e.V.), where participants received the intervention for 12 months and were followed up for up to 9 years with metabolic phenotyping including oral glucose tolerance tests (OGTTs) for glucose metabolism and whole-body magnetic resonance imaging (MRI) for assessment of body fat distribution before and after the intervention and during follow-up (see Methods for details)